Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Mdeg-541 | C35H38N4O6S2 | 5 MG
SDP

Catalog No. 5000375316
Encompass_Preferred

MDEG-541 is a potent MYC-MAX degrader and a PROTAC, derived from the MYC-MAX dimerization inhibitor 10058-F4 (derivative 28RH) and Thalidomide (HY-14658). It exhibits antiproliferative activity and reduces the expression of GSPT1, MYC, GSPT2, and PLK1 proteins. It also decreases the expression of MYC in a dose-dependent manner and inhibits cell viability in HCT116 and PSN1 cells.

  • Potent MYC-MAX degrader
  • PROTAC based on 10058-F4 derivative and Thalidomide
  • Shows antiproliferative activity
  • Decreases expression of GSPT1, MYC, GSPT2, PLK1 protein
  • Inhibits cell viability in HCT116 and PSN1 cells

Catalog No. 50-003-75316 Supplier Medchemexpress LLC Supplier No. HY1502595MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

MDEG-541 is a potent MYC-MAX degrader and a PROTAC, derived from the MYC-MAX dimerization inhibitor 10058-F4 (derivative 28RH) and Thalidomide (HY-14658). It exhibits antiproliferative activity and reduces the expression of GSPT1, MYC, GSPT2, and PLK1 proteins. It also decreases the expression of MYC in a dose-dependent manner and inhibits cell viability in HCT116 and PSN1 cells.

  • Potent MYC-MAX degrader
  • PROTAC based on 10058-F4 derivative and Thalidomide
  • Shows antiproliferative activity
  • Decreases expression of GSPT1, MYC, GSPT2, PLK1 protein
  • Inhibits cell viability in HCT116 and PSN1 cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.